[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Page 69133]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27490]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Morton Grove Pharmaceuticals

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 7, 2013, Morton Grove 
Pharmaceuticals, 6451 Main Street, Morton Grove, Illinois 60053-2633, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric 
Acid (2010), a basic class of controlled substance listed in schedule 
I.
    The company plans to manufacture a controlled substance for product 
development.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODW), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than January 17, 2014.

    Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27490 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P